UniDoc Qualifies to Partner with US S&P500 TelCo
-- Aim to jointly develop and showcase AI eHealth to TelCo customers
VANCOUVER, BC, Sept. 9, 2024 /CNW/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is excited to announce that it has been approved for partnership with one of the largest US-based telecommunications companies ("TelCo"). This partnership aims to integrate their communications services with UniDoc's advanced eHealth platform to deliver a healthcare solution to the TelCo's global community.
Partnership Intention:
- Collaboration: UniDoc and TelCo aim to develop a combination of product offerings to enhancing patient engagement and optimize clinician effectiveness across the healthcare spectrum.
- Integrated Services Offering: The partnership aims to deliver a solution combining telehealth services, and advanced network and communication platforms.
- AI-Enhanced Healthcare: Leveraging UniDoc's AI technologies to improve data analysis, and enabling precision and predictive healthcare with faster diagnosis and treatment options.
UniDoc's CEO, Antonio Baldassarre, remarked, "This approval for partnership marks an exciting first step in our working with TelCo. By combining our eHealth solutions with the TelCo's communications infrastructure, we are excited to work towards expanding access to patient care in the US. This initiative not only broadens our potential market reach but also underscores our commitment to improving healthcare accessibility through cutting-edge technology."
The Company plans to leverage the TelCo's 5G network capabilities to ensure that UniDoc's eHealth solutions are reliably and securely delivered throughout the TelCo's network. Secure and reliable communication is critical in UniDoc's mission to provide seamless healthcare services, especially to underserved populations that lack traditional healthcare infrastructure.
Additionally, the potential integration of TelCo's existing healthcare platforms with the UniDoc solutions could introduce a new level of personalized care, with the goal making it easier for patients to manage their health proactively. This service enhancement aims to transform patient experiences by providing more timely and targeted interventions, driven by real-time data insights and expert medical oversight.
The approval for partnership is the initial step in the development of the relationship between the TelCo and the Company and there can be no assurance that the approval for partnership will result in the development or joint development of products with the Company and TelCo. Accordingly, readers are cautioned that no agreement with TelCo may result from the partnership or upon terms that are favourable or economic for the Company.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the partnership between the Company and TelCo, the features of the distributed care platform to be co-developed with TelCo, that the partnership with TelCo will expand patient care and enhance shareholder value, that the partnership with TelCo will assist the Company in delivering its solutions around the world, and that the Company's healthcare solutions will be offered to TelCo's global customers.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 30, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE UniDoc Health Corp.
For further information, please contact: UniDoc Investor Relations, Tel: +1 778.383.6731, Email: [email protected]; Matt Chatterton, Director, Tel: +1 778.613.2082, Email: [email protected]; Media Inquiries [email protected]
Share this article